Geneos Wealth Management’s British American Tobacco BTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $569K | Buy |
9,216
+7
| +0.1% | +$423 | 0.01% | 696 |
|
|
2026
Q1 | $538K | Sell |
9,209
-363
| -4% | -$21.5K | 0.01% | 679 |
|
|
2025
Q4 | $542K | Sell |
9,572
-107
| -1% | -$5.84K | 0.01% | 638 |
|
|
2025
Q3 | $514K | Sell |
9,679
-306
| -3% | -$16.6K | 0.01% | 639 |
|
|
2025
Q2 | $473K | Buy |
9,985
+6,367
| +176% | +$282K | 0.01% | 727 |
|
|
2025
Q1 | $150K | Buy |
3,618
+1,048
| +41% | +$41.2K | 0.01% | 1029 |
|
|
2024
Q4 | $93.3K | Buy |
2,570
+388
| +18% | +$14K | ﹤0.01% | 1092 |
|
|
2024
Q3 | $79.8K | Sell |
2,182
-240
| -10% | -$8.58K | ﹤0.01% | 1035 |
|
|
2024
Q2 | $74.9K | Buy |
2,422
+6
| +0.2% | +$182 | ﹤0.01% | 949 |
|
|
2024
Q1 | $73.7K | Sell |
2,416
-823
| -25% | -$24.8K | ﹤0.01% | 944 |
|
|
2023
Q4 | $94.9K | Sell |
3,239
-617
| -16% | -$18.8K | ﹤0.01% | 856 |
|
|
2023
Q3 | $121K | Sell |
3,856
-13
| -0.3% | -$429 | 0.01% | 817 |
|
|
2023
Q2 | $128K | Buy |
3,869
+21
| +0.5% | +$718 | 0.01% | 802 |
|
|
2023
Q1 | $135K | Buy |
3,848
+231
| +6% | +$8.71K | 0.01% | 754 |
|
|
2022
Q4 | $145K | Sell |
3,617
-413
| -10% | -$16.2K | 0.01% | 732 |
|
|
2022
Q3 | $143K | Sell |
4,030
-1,980
| -33% | -$79.3K | 0.01% | 697 |
|
|
2022
Q2 | $260K | Sell |
6,010
-1,329
| -18% | -$57K | 0.01% | 658 |
|
|
2022
Q1 | $309K | Buy |
7,339
+132
| +2% | +$5.63K | 0.01% | 657 |
|
|
2021
Q4 | $269K | Buy |
7,207
+1,527
| +27% | +$54.2K | 0.01% | 761 |
|
|
2021
Q3 | $197K | Sell |
5,680
-4,285
| -43% | -$161K | 0.01% | 860 |
|
|
2021
Q2 | $393K | Buy |
9,965
+1,897
| +24% | +$74.3K | 0.02% | 624 |
|
|
2021
Q1 | $302K | Sell |
8,068
-5,596
| -41% | -$211K | 0.01% | 792 |
|
|
2020
Q4 | $531K | Sell |
13,664
-793
| -5% | -$28.4K | 0.02% | 524 |
|
|
2020
Q3 | $521K | Sell |
14,457
-3,936
| -21% | -$138K | 0.03% | 419 |
|
|
2020
Q2 | $712K | Buy |
18,393
+6,295
| +52% | +$241K | 0.04% | 346 |
|
|
2020
Q1 | $391K | Buy |
12,098
+1,884
| +18% | +$76.8K | 0.03% | 422 |
|
|
2019
Q4 | $434K | Sell |
10,214
-253
| -2% | -$9.54K | 0.02% | 472 |
|
|
2019
Q3 | $378K | Buy |
10,467
+2,415
| +30% | +$88.4K | 0.02% | 471 |
|
|
2019
Q2 | $280K | Buy |
8,052
+3,134
| +64% | +$119K | 0.02% | 565 |
|
|
2019
Q1 | $205K | Buy |
4,918
+953
| +24% | +$34.7K | 0.01% | 629 |
|
|
2018
Q4 | $128K | Sell |
3,965
-899
| -18% | -$35K | 0.01% | 750 |
|
|
2018
Q3 | $226K | Buy |
4,864
+521
| +12% | +$26.5K | 0.02% | 597 |
|
|
2018
Q2 | $219K | Sell |
4,343
-904
| -17% | -$47.6K | 0.02% | 546 |
|
|
2018
Q1 | $302K | Sell |
5,247
-317
| -6% | -$19.9K | 0.03% | 419 |
|
|
2017
Q4 | $372K | Sell |
5,564
-1,578
| -22% | -$103K | 0.03% | 384 |
|
|
2017
Q3 | $446K | Buy |
7,142
+6,069
| +566% | +$392K | 0.04% | 324 |
|
|
2017
Q2 | $73K | Buy |
+1,073
| New | +$74.5K | 0.01% | 789 |
|
Other funds holding BTI
OAG
Geneos Wealth Management's BTI Position: Q2 2026 in Review
Geneos Wealth Management increased its British American Tobacco (BTI) stake by 0.08% in Q2 2026, buying an estimated $423 and bringing the position to 9,216 shares worth $569K. The position accounts for 0.01% of the portfolio, ranked #696.
Geneos Wealth Management first reported a position in BTI in Q2 2017 and has held it in 37 quarters since. The position peaked at $712K in Q2 2020. 909 funds tracked by Wall St. Rank hold BTI as of Q2 2026.
- Geneos Wealth Management held 9,216 shares of British American Tobacco worth $569K as of Q2 2026.
- Geneos Wealth Management bought 7 British American Tobacco shares in Q2 2026, an estimated $423.
- British American Tobacco made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #696 holding.
- Geneos Wealth Management first reported a position in British American Tobacco in Q2 2017 and has held it in 37 quarters since.
- Geneos Wealth Management's British American Tobacco position peaked at $712K in Q2 2020.
- 909 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.